InvestorsHub Logo
Followers 12
Posts 940
Boards Moderated 0
Alias Born 04/07/2019

Re: north40000 post# 424009

Tuesday, 05/07/2024 6:14:50 AM

Tuesday, May 07, 2024 6:14:50 AM

Post# of 426436
Thanks North. I wonder what PFE's thoughts are of their involvement with V in Canada in the relationshiop through HLS. Do they view Vascepa as a successful drug to promote in the US or in the world? Are they better suited to sell V in EU than say Novo Nordisk who is more Europe centric?
I 'll state the obvious that everyone knows.
We need;
A positive response from the judges regarding the Hikma case to move
Italy and France on board in Europe. And of course Germany but that is 2025 timeline.
Buyback of shares
New indications for V
New US product in either packaging or Mochida product to fight generics
Probably more, but it seems to me that all of this will occur before EOY '24
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News